Skip to main content
Top
Published in: Diabetologia 5/2007

01-05-2007 | Short Communication

Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians

Authors: M. Traurig, R. L. Hanson, S. Kobes, C. Bogardus, L. J. Baier

Published in: Diabetologia | Issue 5/2007

Login to get access

Abstract

Aim/hypothesis

Single-nucleotide polymorphisms (SNPs) in the protein tyrosine phosphatase 1B gene (PTPN1) have been reported to be associated with type 2 diabetes in white subjects, and insulin sensitivity and fasting glucose levels in Hispanic Americans. In this study, we determined whether SNPs in PTPN1 also have a role in type 2 diabetes susceptibility in Pima Indians, a population with the world’s highest reported prevalence and incidence rates of this disease.

Materials and methods

Thirty-one SNPs across a 161-kb region encompassing PTPN1 were genotyped in 1,037 Pima Indians for association studies with type 2 diabetes and obesity.

Results

Twenty-five of the SNPs had allele frequencies >0.05, and these SNPs fell into two linkage disequilibrium blocks (D′  > 0.9). Block 1 contains six SNPs that span a 61-kb region upstream of PTPN1, while block 2 contains 19 SNPs that cover the entire PTPN1 gene. None of the SNPs, analysed individually or as haplotypes, was associated with either type 2 diabetes or obesity. However, three SNPs located in block 1 were nominally associated (p values ranging from 0.01 to 0.05) with insulin sensitivity as measured by the hyperinsulinaemic–euglycaemic clamp technique.

Conclusions/interpretation

Based on our association results, we conclude that SNPs within PTPN1 are unlikely to have a major role in the aetiology of type 2 diabetes or obesity in Pima Indians.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ghosh S, Watanabe RM, Valle TT et al (2000) The Finland–United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 67:1174–1185PubMed Ghosh S, Watanabe RM, Valle TT et al (2000) The Finland–United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. I. An autosomal genome scan for genes that predispose to type 2 diabetes. Am J Hum Genet 67:1174–1185PubMed
2.
go back to reference Bento JL, Palmer ND, Mychaleckyj JC et al (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53:3007–3012PubMedCrossRef Bento JL, Palmer ND, Mychaleckyj JC et al (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes 53:3007–3012PubMedCrossRef
3.
go back to reference Palmer ND, Bento JL, Mychaleckyj JC et al (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 53:3013–3019PubMedCrossRef Palmer ND, Bento JL, Mychaleckyj JC et al (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 53:3013–3019PubMedCrossRef
4.
go back to reference Florez JC, Agapakis CM, Burtt NP et al (2005) Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people. Diabetes 54:1884–1891PubMedCrossRef Florez JC, Agapakis CM, Burtt NP et al (2005) Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people. Diabetes 54:1884–1891PubMedCrossRef
5.
go back to reference Spencer-Jones NJ, Wang X, Snieder H, Spector TD, Carter ND, O’Dell SD (2005) Protein tyrosine phosphatase-1b gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. Diabetes 54:3296–3304PubMedCrossRef Spencer-Jones NJ, Wang X, Snieder H, Spector TD, Carter ND, O’Dell SD (2005) Protein tyrosine phosphatase-1b gene PTPN1: selection of tagging single nucleotide polymorphisms and association with body fat, insulin sensitivity, and the metabolic syndrome in a normal female population. Diabetes 54:3296–3304PubMedCrossRef
6.
go back to reference Cheyssac C, Lecoeur C, Dechaume A et al (2006) Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population. BMC Med Genet 7:44PubMedCrossRef Cheyssac C, Lecoeur C, Dechaume A et al (2006) Analysis of common PTPN1 gene variants in type 2 diabetes, obesity and associated phenotypes in the French population. BMC Med Genet 7:44PubMedCrossRef
7.
go back to reference Knowler WC, Pettitt DJ, Saad MF, Bennett PH (1990) Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 6:1–27PubMedCrossRef Knowler WC, Pettitt DJ, Saad MF, Bennett PH (1990) Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 6:1–27PubMedCrossRef
8.
go back to reference Vozarova de Courten B, Hanson RL, Funahashi T et al (2005) Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 54:284–289PubMedCrossRef Vozarova de Courten B, Hanson RL, Funahashi T et al (2005) Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 54:284–289PubMedCrossRef
9.
go back to reference Lillioja S, Mott DM, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988–1992PubMedCrossRef Lillioja S, Mott DM, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988–1992PubMedCrossRef
10.
go back to reference Hanson RL, Looker HC, Ma L, Muller YL, Baier LJ, Knowler WC (2006) Design and analysis of genetic association studies to finely map a locus identified by linkage analysis: sample size and power calculations. Ann Hum Genet 70:332–349PubMedCrossRef Hanson RL, Looker HC, Ma L, Muller YL, Baier LJ, Knowler WC (2006) Design and analysis of genetic association studies to finely map a locus identified by linkage analysis: sample size and power calculations. Ann Hum Genet 70:332–349PubMedCrossRef
11.
go back to reference Ukkola O, Rankinen T, Lakka T et al (2005) Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism. Obes Res 13:829–834PubMedCrossRef Ukkola O, Rankinen T, Lakka T et al (2005) Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism. Obes Res 13:829–834PubMedCrossRef
12.
go back to reference Echwald SM, Bach H, Vestergaard H et al (2002) A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 51:1–6PubMedCrossRef Echwald SM, Bach H, Vestergaard H et al (2002) A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 51:1–6PubMedCrossRef
Metadata
Title
Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians
Authors
M. Traurig
R. L. Hanson
S. Kobes
C. Bogardus
L. J. Baier
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2007
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0611-6

Other articles of this Issue 5/2007

Diabetologia 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine